Survey of cyclosporin-sparing agent use in Australasian transplant centres

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 6, 1996, Pages 772-776

  Jones, T E ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Austr alia; cyclosporin; diltiazem; interaction; ketoconazole; New Zealand; sparing agents; survey; transplantation

Indexed keywords

CIMETIDINE; CYCLOSPORIN; DILTIAZEM; KETOCONAZOLE;

ARTICLE; AUSTRALIA; DRUG CHOICE; DRUG COST; DRUG USE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORGAN TRANSPLANTATION;

EID: 0030468808     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb00623.x     Document Type: Article

References (15)

1. Neumayer HH, Wagner K. Diltiazem and economic use of cyclosporin. Lancet 1986; ii: 523.
2. Kohlaw K, Wonigeit K, Frei U, Oldhafer K, Neumann K, Pichlmayr R. Effect of the calcium channel blocker diltiazem on cyclosporin A blood levels and dose requirements. Transplant Proc 1988; XX, No 2 Suppl 2: 572-4.
3. Brockmoller J, Neumayer HH, Wagner K et al. Pharmacokinetic interaction between cyclosporin and diltiazem. Eur J Clin Pharmacol 1990; 38: 237-42.
4. Epstein M. Calcium antagonists and renal protection. Arch Intern Med 1992; 152: 1573-84.
5. Chrysostomou A, Walker RG, Russ GR et al. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 1993; 55: 300-4.
6. Vasquez EM, Pollak R. Effect of calcium channel blockers on graft outcome in cyclosporine-treated renal allograft recipients. Transplantation 1995; 60: 885-7.
7. First MR, Schroeder TJ, Michela A, Hariharan S, Weiskittel P, Alexander JW. Cyclosporine-ketoconazole interaction. Long term follow up and preliminary results of a randomized trial. Transplantation 1993; 55: 1000-4.
8. Keogh A, Spratt P, McCosker C, Macdonald P, Mundy J, Kaan A. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 1995; 333: 628-33.
9. Burckart GJ, Venkataramanan R, Ptachcinski RJ et al. Cyclosporine absorption following orthoptic liver transplantation. J Clin Pharmacol 1986; 26: 647-51.
10. Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water soluble vitamin E. Lancet 1991; 338: 212-5.
11. Grevel J. Absorption of cyclosporine A after oral dosing. Transplant Proc 1986; 18 Suppl 5: 9-15.
12. Wu CY, Benet LZ, Hebert MF et al. Differentiation of absorption and first pass gut and hepatic metabolism in humans: Studies with cyclosporine. Clin Pharmacol Ther 1995; 58: 492-7.
13. Hollander AAMJ, van Rooij J, Lentjes EGWM et al. The effect of grapefruit juice on cyclosporine and prednisolone metabolism in transplant patients. Clin Pharmacol Ther 1995; 57: 318-24.
14. Lindholm A, Henricsson S, Dahlqvist R. The effect of bile acid administration on the relative bioavailability of cyclosporin. Br J Clin Pharmacol 1990; 29: 541-8.
15. Tester-Dalderup CBM. Antifungal drugs. In: Dukes MNG (Ed.). Meyler's side effects of drugs, 12th edn. Amsterdam: Elsevier Science Publishers BV, 1992; 672-86.